APA (7th ed.) Citation

KR, G., J, V., MS, C., S, W., TF, D., F, D., . . . AL, N. (2019). Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC. Translational oncology, 12(3), 432. https://doi.org/10.1016/j.tranon.2018.11.017

Chicago Style (17th ed.) Citation

KR, Gammelgaard, Vad-Nielsen J, Clement MS, Weiss S, Daugaard TF, Dagnæs-Hansen F, Meldgaard P, Sorensen BS, and Nielsen AL. "Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC." Translational Oncology 12, no. 3 (2019): 432. https://doi.org/10.1016/j.tranon.2018.11.017.

MLA (9th ed.) Citation

KR, Gammelgaard, et al. "Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLC." Translational Oncology, vol. 12, no. 3, 2019, p. 432, https://doi.org/10.1016/j.tranon.2018.11.017.